1 The findings showed: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) As a retrospective analysis, this study has limitations including potential confounding factors, and definitive randomised controlled trials are needed to confirm any disease-modifying effects of GLP-1 medications in MS
Alpha Lipoic Acid: The Universal Regenerator Alpha Lipoic Acid (ALA) is often called the "universal antioxidant" because it is both water- and fat-soluble
It is important to emphasize that due to the distinct physiological characteristics of biologics, such as stability, specificity, selectivity, and capacity to inhibit particular protein-protein interactions, the biologics sector is expected to expand at a comparatively higher CAGR
10.1185/03007990802418851 42 Del PratoS
Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial
/assets/images/provider/photos/2798511.png)
